Harriet Johansson

17PUBLICATIONS
102CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targetsModels of care and place of birthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 30, 2025
Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis.

Irene Maria Briata, Stefano Spinaci, Parijatham S Thomas

|Oct 16, 2025
Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study.

Silvia Polidoro, Harriet Johansson, Giovanni Cugliari

|Jun 09, 2025
Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer prevention.

G Aurilio, D Serrano, M Lazzeroni

|Apr 28, 2025
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial.

Harriet Johansson, Debora Macis, Martino Oliva

|Jul 13, 2024
A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial.

Debora Macis, Federica Bellerba, Valentina Aristarco

|Apr 13, 2024
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up Study.

Massimiliano Ruscica, Chiara Macchi, Sara Gandini

Pageof 3

Frequent Collaborators

14 joint publications

Bernardo Bonanni

11 joint publications

Debora Macis

9 joint publications

Aliana Guerrieri-Gonzaga

9 joint publications

Valentina Aristarco